# Prophylactic Alpha-blockers in the Prevention of Urinary Retention Post Inguinal Hernia Repair

> **NCT03314259** · EARLY_PHASE1 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 300 (estimated)

## Conditions studied

- Urinary Retention
- Inguinal Hernia

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03314259
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314259, "Prophylactic Alpha-blockers in the Prevention of Urinary Retention Post Inguinal Hernia Repair". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03314259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*